• N&PD Moderators: Skorpio | someguyontheinternet

Cendifensine (NOE-115) {SNDRI in clinical trials}

Smyth2

Bluelighter
Joined
Jul 26, 2011
Messages
489
Did a patent search yesterday on SNDRIs and found the following:

[1] George GARIBALDI, WO2023161533 (to Noema Pharma AG).
[2] Jean-Michel Adam, et al. WO2013160273 (to F Hoffmann La Roche AG).
[3] Pravin Iyer, et al. WO2008074703 (to Roche Palo Alto LLC).
[4] Lucas, M. C., Weikert, R. J., Carter, D. S., Cai, H.-Y., Greenhouse, R., Iyer, P. S., Lin, C. J., Lee, E. K., Madera, A. M., Moore, A., Ozboya, K., Schoenfeld, R. C., Steiner, S., Zhai, Y., Lynch, S. M. (September 2010). "Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain". Bioorganic & Medicinal Chemistry Letters. 20 (18): 5559–5566. doi:10.1016/j.bmcl.2010.07.020.

I checked the website
It could be that the compound is NOE-115 but it is still too early to say.
On this webpage it says NOE-115 "The therapeutic candidate is a triple reuptake inhibitor targeting, sodium dependent dopamine transporter, sodium dependent noradrenaline transporter and sodium dependent serotonin transporter. It is administered through oral route as a capsule."
 
Last edited:
The compound was first prepared many years ago but I believe it was analgesic activity that it was screened for.
 
Last edited:
Well, the concept of treating depression and pain makes sense, but I have mentioned that if you produce a medicine that has two entirely different activities, practicioners cannot titrate to the dose of antidepressant and analgesic seperately.

Also the history of antidepressants is chequred to say the least.
 
Aren't you optimistic about a novel SNDRI agent to reach the market?

I bought 10g of tesofensine from alibaba once and it was such garbage I thought i'd been scammed.
 
No even slightly - read the history.
 
Last edited:
Top